Cravatex Limited Board approved audited standalone and consolidated financial results for FY26 ended March 31, 2026, with auditors issuing an unmodified opinion.
Recommended a final dividend of Rs. 13 per share (130%) for FY26, subject to shareholder approval at the AGM on July 31, 2026.
Appointed M/s Hemanshu Kapadia & Associates as Secretarial Auditors for FY27 and set book closure from July 25 to July 31, 2026 for dividend entitlement.